{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:06:17Z","timestamp":1794513977046,"version":"4.9.1"},"reference-count":240,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lam Kin Chung. Jet King-Shing Ho Glaucoma Treatment and Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mitochondrial dysfunction is a core pathogenic mechanism underlying a broad spectrum of neurodegenerative disorders, from Alzheimer\u2019s and Parkinson\u2019s diseases to inherited optic neuropathies and mitochondrial ataxias. This review provides a comprehensive analysis of how defects in mitochondrial and nuclear DNA converge to disrupt oxidative phosphorylation, mitochondrial dynamics, calcium homeostasis, and quality control pathways, leading to energy depletion, oxidative stress, and neuronal degeneration across multiple disease contexts. Building on this mechanistic foundation, we examine how these shared pathogenic principles manifest distinctly in major neurodegenerative diseases, while also discussing representative mitochondrial optic neuropathies as tractable disease models that have yielded critical mechanistic and therapeutic insights. We further review recent advances in diagnostic technologies that enhance our ability to detect and stratify mitochondrial pathologies for therapeutic intervention. On the therapeutic front, we provide a comprehensive evaluation of the rapidly evolving landscape, analyzing strategies ranging from metabolic modulators and antioxidants to pioneering gene-targeted therapies, organelle replacement approaches, and emerging epitranscriptomic interventions. Finally, we identify persistent challenges in clinical translation and outline pivotal future directions essential for developing effective, mechanism-informed combination therapies against mitochondrial dysfunction in neurodegeneration.<\/jats:p>","DOI":"10.1186\/s43556-026-00480-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:35:39Z","timestamp":1779935739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances"],"prefix":"10.1186","volume":"7","author":[{"given":"Yan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Na","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Wong Ying","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemlata","family":"Bisnauthsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poemen P.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2903-3247","authenticated-orcid":false,"given":"Wai Kit","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"0","key":"480_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1101\/sqb.2009.74.031","volume":"74","author":"DC Wallace","year":"2009","unstructured":"Wallace DC. Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolution. Cold Spring Harb Symp Quant Biol. 2009;74(0):383\u201393. https:\/\/doi.org\/10.1101\/sqb.2009.74.031.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"480_CR2","doi-asserted-by":"publisher","unstructured":"Mustafa MF, Fakurazi S, Abdullah MA, Maniam S. Pathogenic Mitochondria DNA Mutations: Current Detection Tools and Interventions. Genes. 2020;11(2). https:\/\/doi.org\/10.3390\/genes11020192.","DOI":"10.3390\/genes11020192"},{"key":"480_CR3","doi-asserted-by":"publisher","unstructured":"Zeviani M, Carelli V. Mitochondrial Retinopathies. Int J Mol Sci. 2021;23(1). https:\/\/doi.org\/10.3390\/ijms23010210.","DOI":"10.3390\/ijms23010210"},{"issue":"6","key":"480_CR4","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/j.1471-4159.2006.03990.x","volume":"97","author":"JQ Kwong","year":"2006","unstructured":"Kwong JQ, Beal MF, Manfredi G. The role of mitochondria in inherited neurodegenerative diseases. J Neurochem. 2006;97(6):1659\u201375. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03990.x.","journal-title":"J Neurochem"},{"issue":"7113","key":"480_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787\u201395. https:\/\/doi.org\/10.1038\/nature05292.","journal-title":"Nature"},{"issue":"2","key":"480_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies \u2013 disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81\u2013114. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"480_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrg1606","volume":"6","author":"RW Taylor","year":"2005","unstructured":"Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005;6(5):389\u2013402. https:\/\/doi.org\/10.1038\/nrg1606.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"480_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/s0968-0004(00)01674-1","volume":"25","author":"S Raha","year":"2000","unstructured":"Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci. 2000;25(10):502\u20138. https:\/\/doi.org\/10.1016\/s0968-0004(00)01674-1.","journal-title":"Trends Biochem Sci"},{"key":"480_CR9","doi-asserted-by":"publisher","unstructured":"Hu S, Yang Z, Bao K, Hou W, Qin Y, Wu C, et al. Mitochondrial dynamics in neurodegenerative diseases: Research hotspots and trends from 2005 to 2025. Ageing Res Rev. 2026;114. https:\/\/doi.org\/10.1016\/j.arr.2025.102987.","DOI":"10.1016\/j.arr.2025.102987"},{"issue":"2","key":"480_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","volume":"26","author":"L-C T\u00e1bara","year":"2024","unstructured":"T\u00e1bara L-C, Segawa M, Prudent J. Molecular mechanisms of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2024;26(2):123\u201346. https:\/\/doi.org\/10.1038\/s41580-024-00785-1.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"480_CR11","doi-asserted-by":"publisher","unstructured":"Zacharioudakis E, Agianian B, Kumar Mv V, Biris N, Garner TP, Rabinovich-Nikitin I, et al. Modulating mitofusins to control mitochondrial function and signaling. Nat Commun. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-022-31324-1.","DOI":"10.1038\/s41467-022-31324-1"},{"issue":"8","key":"480_CR12","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","volume":"30","author":"P Bernardi","year":"2023","unstructured":"Bernardi P, Gerle C, Halestrap AP, Jonas EA, Karch J, Mnatsakanyan N, et al. Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ. 2023;30(8):1869\u201385. https:\/\/doi.org\/10.1038\/s41418-023-01187-0.","journal-title":"Cell Death Differ"},{"key":"480_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2018.07.014","volume":"202","author":"B Banoth","year":"2018","unstructured":"Banoth B, Cassel SL. Mitochondria in innate immune signaling. Transl Res. 2018;202:52\u201368. https:\/\/doi.org\/10.1016\/j.trsl.2018.07.014.","journal-title":"Transl Res"},{"issue":"6769","key":"480_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.adr5438","volume":"390","author":"M Frison","year":"2025","unstructured":"Frison M, Lockey BS, Nie Y, Golder Z, Theiaspra E, Ryall CD, et al. Ubiquitin-mediated mitophagy regulates the inheritance of mitochondrial DNA mutations. Science. 2025;390(6769):156\u201363. https:\/\/doi.org\/10.1126\/science.adr5438.","journal-title":"Science"},{"key":"480_CR15","doi-asserted-by":"publisher","unstructured":"Bora P, Zaman M, Oviedo S, Kutseikin S, Madrazo N, Mathur P, et al. Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cells. Proc Natl Acad Sci U S A. 2025;122(48). https:\/\/doi.org\/10.1073\/pnas.2517552122.","DOI":"10.1073\/pnas.2517552122"},{"issue":"10","key":"480_CR16","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41556-025-01774-y","volume":"27","author":"M Nguyen","year":"2025","unstructured":"Nguyen M, Collier JJ, Ignatenko O, Morin G, Goyon V, Janer A, et al. MAPL regulates gasdermin-mediated release of mtDNA from lysosomes to drive pyroptotic cell death. Nat Cell Biol. 2025;27(10):1708\u201324. https:\/\/doi.org\/10.1038\/s41556-025-01774-y.","journal-title":"Nat Cell Biol"},{"key":"480_CR17","doi-asserted-by":"publisher","unstructured":"Lambert M, Hanley JA, Robinson BH, Allard P, Mitchell GA, Debray Fo-G. Diagnostic Accuracy of Blood Lactate-to-Pyruvate Molar Ratio in the Differential Diagnosis of Congenital Lactic Acidosis. Clin Chem. 2007;53(5):916\u201321. https:\/\/doi.org\/10.1373\/clinchem.2006.081166.","DOI":"10.1373\/clinchem.2006.081166"},{"key":"480_CR18","doi-asserted-by":"publisher","unstructured":"Risi B, Imarisio A, Cuconato G, Padovani A, Valente EM, Filosto M. Mitochondrial DNA (mtDNA) as fluid biomarker in neurodegenerative disorders: A systematic review. Eur J Neurol. 2025;32(1). https:\/\/doi.org\/10.1111\/ene.70014.","DOI":"10.1111\/ene.70014"},{"key":"480_CR19","doi-asserted-by":"publisher","unstructured":"Wedel S, Martic I, Guerrero Navarro L, Ploner C, Pierer G, Jansen\u2010D\u00fcrr P, et al. Depletion of growth differentiation factor 15 (GDF15) leads to mitochondrial dysfunction and premature senescence in human dermal fibroblasts. Aging Cell. 2022;22(1). https:\/\/doi.org\/10.1111\/acel.13752.","DOI":"10.1111\/acel.13752"},{"issue":"12","key":"480_CR20","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1977","unstructured":"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74(12):5463\u20137. https:\/\/doi.org\/10.1073\/pnas.74.12.5463.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"480_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1080\/23802359.2018.1501287","volume":"3","author":"L Li","year":"2018","unstructured":"Li L, Xing R, Cui J, Li W, Lu Y. Investigation of frequent somatic mutations of MTND5 gene in gastric cancer cell lines and tissues. Mitochondrial DNA B. 2018;3(2):1002\u20138. https:\/\/doi.org\/10.1080\/23802359.2018.1501287.","journal-title":"Mitochondrial DNA B"},{"issue":"5","key":"480_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrg1325","volume":"5","author":"J Shendure","year":"2004","unstructured":"Shendure J, Mitra RD, Varma C, Church GM. Advanced sequencing technologies: methods and goals. Nat Rev Genet. 2004;5(5):335\u201344. https:\/\/doi.org\/10.1038\/nrg1325.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"480_CR23","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/nprot.2014.170","volume":"9","author":"SR Kennedy","year":"2014","unstructured":"Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, Ahn EH, et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nat Protoc. 2014;9(11):2586\u2013606. https:\/\/doi.org\/10.1038\/nprot.2014.170.","journal-title":"Nat Protoc"},{"key":"480_CR24","doi-asserted-by":"publisher","unstructured":"Marquis J, Lefebvre G, Kourmpetis YAI, Kassam M, Ronga F, De Marchi U, et al. MitoRS, a method for high throughput, sensitive, and accurate detection of mitochondrial DNA heteroplasmy. BMC Genomics. 2017;18(1). https:\/\/doi.org\/10.1186\/s12864-017-3695-5.","DOI":"10.1186\/s12864-017-3695-5"},{"issue":"5","key":"480_CR25","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41596-022-00795-3","volume":"18","author":"CA Lareau","year":"2023","unstructured":"Lareau CA, Liu V, Muus C, Praktiknjo SD, Nitsch L, Kautz P, et al. Mitochondrial single-cell ATAC-seq for high-throughput multi-omic detection of mitochondrial genotypes and chromatin accessibility. Nat Protoc. 2023;18(5):1416\u201340. https:\/\/doi.org\/10.1038\/s41596-022-00795-3.","journal-title":"Nat Protoc"},{"issue":"2","key":"480_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.apsb.2021.06.014","volume":"12","author":"SN Austad","year":"2022","unstructured":"Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL, Darley-Usmar V, et al. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer\u2019s disease. Acta Pharm Sin B. 2022;12(2):511\u201331. https:\/\/doi.org\/10.1016\/j.apsb.2021.06.014.","journal-title":"Acta Pharm Sin B"},{"issue":"19","key":"480_CR27","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 2010;75(19):1702\u201310. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc27e4.","journal-title":"Neurology"},{"issue":"9","key":"480_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2015;17(9):689\u2013701. https:\/\/doi.org\/10.1038\/gim.2014.177.","journal-title":"Genet Med"},{"key":"480_CR29","doi-asserted-by":"publisher","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1). https:\/\/doi.org\/10.1038\/s41392-024-02044-3.","DOI":"10.1038\/s41392-024-02044-3"},{"issue":"5","key":"480_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1474-4422(18)30499-x","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x.","journal-title":"Lancet Neurol"},{"key":"480_CR31","doi-asserted-by":"publisher","unstructured":"Mitochondrial Dysfunction in Alzheimer\u2019s disease: Focus on Dynamics and Electron Transport Chain. Aging Dis. 2025. https:\/\/doi.org\/10.14336\/ad.2025.1046.","DOI":"10.14336\/ad.2025.1046"},{"key":"480_CR32","doi-asserted-by":"publisher","unstructured":"de Aguiar da Costa M, de Rezende VL, Bolan SJ, Ebs MFP, da Silva G, Pellegrini L, et al. Brain aging in neurodevelopmental disorders: a narrative review of oxidative, inflammatory, and mitochondrial mechanisms. Neurodegener Dis Manag. 2026:1\u201322. https:\/\/doi.org\/10.1080\/17582024.2026.2623966.","DOI":"10.1080\/17582024.2026.2623966"},{"key":"480_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","volume":"179","author":"E Salmon","year":"2024","unstructured":"Salmon E, Collette F, Bastin C. Cerebral glucose metabolism in Alzheimer\u2019s disease. Cortex. 2024;179:50\u201361. https:\/\/doi.org\/10.1016\/j.cortex.2024.07.004.","journal-title":"Cortex"},{"issue":"3","key":"480_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360. https:\/\/doi.org\/10.1038\/s41583-019-0132-6.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"480_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3233\/jad-190476","volume":"72","author":"DR Pepperberg","year":"2019","unstructured":"Pepperberg DR. Amyloid-\u03b2-dependent inactivation of the mitochondrial electron transport chain at low transmembrane potential: an ameliorating process in hypoxia-associated neurodegenerative disease? J Alzheimers Dis. 2019;72(3):663\u201375. https:\/\/doi.org\/10.3233\/jad-190476.","journal-title":"J Alzheimers Dis"},{"key":"480_CR36","doi-asserted-by":"publisher","unstructured":"Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, et al. Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease. Nat Commun. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-021-27572-2.","DOI":"10.1038\/s41467-021-27572-2"},{"key":"480_CR37","doi-asserted-by":"publisher","unstructured":"Ren D, Zhu H, Zhang T, Xiao L, Xu J, Li R. Hypermethylation of FGF13 Reduces Microtubule Stability via Interaction With TUBB2A to Promote Mitochondrial Dysfunction in Alzheimer's Disease. FASEB J. 2026;40(6). https:\/\/doi.org\/10.1096\/fj.202504152R.","DOI":"10.1096\/fj.202504152R"},{"key":"480_CR38","doi-asserted-by":"publisher","unstructured":"Li H. Molecular structure and protein function of mitochondrial fusion protein Mfn2 alleviate Alzheimer's disease: exercise assisted regulation. Int J Biol Macromol. 2025;311. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143696.","DOI":"10.1016\/j.ijbiomac.2025.143696"},{"key":"480_CR39","doi-asserted-by":"publisher","unstructured":"Alavi MV, Fuhrmann N. Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol Neurodegener. 2013;8(1). https:\/\/doi.org\/10.1186\/1750-1326-8-32.","DOI":"10.1186\/1750-1326-8-32"},{"issue":"12","key":"480_CR40","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1080\/15548627.2024.2389474","volume":"20","author":"M Di Rienzo","year":"2024","unstructured":"Di Rienzo M, Romagnoli A, Refolo G, Vescovo T, Ciccosanti F, Zuchegna C, et al. Role of AMBRA1 in mitophagy regulation: emerging evidence in aging-related diseases. Autophagy. 2024;20(12):2602\u201315. https:\/\/doi.org\/10.1080\/15548627.2024.2389474.","journal-title":"Autophagy"},{"key":"480_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202522572","author":"Y Li","year":"2026","unstructured":"Li Y, Yu S, Lu K, Zhang Y, Dong M, Peng Y, et al. ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer\u2019s Amyloid-\u03b2 Pathology. Adv Sci. 2026. https:\/\/doi.org\/10.1002\/advs.202522572.","journal-title":"Adv Sci"},{"issue":"12","key":"480_CR42","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1080\/15548627.2024.2383145","volume":"20","author":"J Yi","year":"2024","unstructured":"Yi J, Wang H-L, Lu G, Zhang H, Wang L, Li Z-Y, et al. Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an Alzheimer disease animal model. Autophagy. 2024;20(12):2655\u201376. https:\/\/doi.org\/10.1080\/15548627.2024.2383145.","journal-title":"Autophagy"},{"key":"480_CR43","doi-asserted-by":"publisher","unstructured":"Sarasija S, Laboy JT, Ashkavand Z, Bonner J, Tang Y, Norman KR. Presenilin mutations deregulate mitochondrial Ca2+ homeostasis and metabolic activity causing neurodegeneration in Caenorhabditis elegans. eLife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.33052.","DOI":"10.7554\/eLife.33052"},{"key":"480_CR44","doi-asserted-by":"publisher","unstructured":"Panes-Fernandez J, Godoy PA, Gavilan J, Ram\u00edrez-Molina O, Burgos CF, Marileo A, et al. TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer's disease. Biomed Pharmacother. 2023;162. https:\/\/doi.org\/10.1016\/j.biopha.2023.114596.","DOI":"10.1016\/j.biopha.2023.114596"},{"issue":"5","key":"480_CR45","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.7150\/ijbs.120062","volume":"22","author":"Y-H Yen","year":"2026","unstructured":"Yen Y-H, Yuan F, Tang D, Luo J-F, Ming C, Kang P-J, et al. APP deficiency ameliorates FAD presenilin 1 F105C and A246E mutations-induced mitochondrial dysfunction in human cortical neurons. Int J Biol Sci. 2026;22(5):2720\u201335. https:\/\/doi.org\/10.7150\/ijbs.120062.","journal-title":"Int J Biol Sci"},{"key":"480_CR46","doi-asserted-by":"publisher","unstructured":"Liu T, Zhang W, Bao W, Wang X, Zhang F, Guo J, et al. A\u03b2 impairs bone vascular homeostasis in APP\/PS1 mice via disrupting the mitochondrial fission-efferocytosis axis in macrophages. Int Immunopharmacol. 2025;165. https:\/\/doi.org\/10.1016\/j.intimp.2025.115526.","DOI":"10.1016\/j.intimp.2025.115526"},{"key":"480_CR47","doi-asserted-by":"publisher","unstructured":"Gao H, Jensen K, Nesbitt J, Ostroot M, Cary GA, Wiley J, et al. Mitochondrial complex I deficiency induces Alzheimer\u2019s disease\u2013like signatures that are reversible by targeted therapy. Alzheimers Dement. 2025;21(8). https:\/\/doi.org\/10.1002\/alz.70519.","DOI":"10.1002\/alz.70519"},{"key":"480_CR48","doi-asserted-by":"publisher","unstructured":"Zhang Q, Zhang W, Yuan X, Peng X, Hu G. Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges. Biomedicines. 2025;13(7). https:\/\/doi.org\/10.3390\/biomedicines13071553.","DOI":"10.3390\/biomedicines13071553"},{"issue":"12","key":"480_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1042\/bcj20253079","volume":"482","author":"MM Alhadidy","year":"2025","unstructured":"Alhadidy MM, Mueller RL, Lamp J, Kanaan NM. Polyamination with spermidine enhances pathogenic tau conformations while reducing filamentous aggregate formation in vitro. Biochem J. 2025;482(12):877\u201399. https:\/\/doi.org\/10.1042\/bcj20253079.","journal-title":"Biochem J"},{"key":"480_CR50","doi-asserted-by":"publisher","unstructured":"Li M, Chen S, Guo R, Wang Y, Yang M, Liu Y, et al. Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for Alzheimer's disease therapy. Signal Transduct Target Ther. 2025;10(1). https:\/\/doi.org\/10.1038\/s41392-025-02453-y.","DOI":"10.1038\/s41392-025-02453-y"},{"issue":"3","key":"480_CR51","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","volume":"46","author":"M Pszczo\u0142owska","year":"2024","unstructured":"Pszczo\u0142owska M, Walczak K, Mi\u015bk\u00f3w W, Mroziak M, Chojdak-\u0141ukasiewicz J, Leszek J. Mitochondrial disorders leading to Alzheimer\u2019s disease\u2014perspectives of diagnosis and treatment. GeroScience. 2024;46(3):2977\u201388. https:\/\/doi.org\/10.1007\/s11357-024-01118-y.","journal-title":"GeroScience"},{"key":"480_CR52","doi-asserted-by":"publisher","unstructured":"Qian W, Liu D, Liu J, Liu M, Ji Q, Zhang B, et al. The Mitochondria\u2010Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation. Small. 2024;21(6). https:\/\/doi.org\/10.1002\/smll.202408581.","DOI":"10.1002\/smll.202408581"},{"key":"480_CR53","doi-asserted-by":"publisher","unstructured":"Li H, Chen Z, Shen Y, Xiong T, Chen A, Chen L, et al. Gene therapy in A\u03b2-induced cell and mouse models of Alzheimer's disease through compensating defective mitochondrial complex I function. J Transl Med. 2024;22(1). https:\/\/doi.org\/10.1186\/s12967-024-05571-3.","DOI":"10.1186\/s12967-024-05571-3"},{"key":"480_CR54","doi-asserted-by":"publisher","unstructured":"Basri R, Al-kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE-S. PACAP: A promising disease-modifying target for Alzheimer's disease. Life Sci. 2026;386. https:\/\/doi.org\/10.1016\/j.lfs.2025.124176.","DOI":"10.1016\/j.lfs.2025.124176"},{"key":"480_CR55","doi-asserted-by":"publisher","unstructured":"Liu Y, Dong Y, Cao Z, Ji Y, Cheng X, Zheng X. The Multi-Dimensional Action Map of Resveratrol Against Alzheimer\u2019s Disease: Mechanism Integration and Treatment Strategy Optimization. Nutrients. 2025;17(21). https:\/\/doi.org\/10.3390\/nu17213451.","DOI":"10.3390\/nu17213451"},{"issue":"6","key":"480_CR56","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou Y, Chu X, Park JH, Zhu Q, Hussain M, Li Z, et al. Urolithin A improves Alzheimer\u2019s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement. 2024;20(6):4212\u201333. https:\/\/doi.org\/10.1002\/alz.13847.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"480_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/alz.12156","volume":"17","author":"ED Vidoni","year":"2020","unstructured":"Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, et al. Safety and target engagement profile of two oxaloacetate doses in Alzheimer\u2019s patients. Alzheimers Dement. 2020;17(1):7\u201317. https:\/\/doi.org\/10.1002\/alz.12156.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"480_CR58","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/alz.12468","volume":"18","author":"E Horgusluoglu","year":"2021","unstructured":"Horgusluoglu E, Neff R, Song WM, Wang M, Wang Q, Arnold M, et al. Integrative metabolomics\u2010genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease. Alzheimers Dement. 2021;18(6):1260\u201378. https:\/\/doi.org\/10.1002\/alz.12468.","journal-title":"Alzheimers Dement"},{"key":"480_CR59","doi-asserted-by":"publisher","unstructured":"Theunissen F, Flynn L, Iacoangeli A, Al Khleifat A, Al-Chalabi A, Giordano JJ, et al. Entering the era of precision medicine to treat amyotrophic lateral sclerosis. Mol Neurodegener. 2025;20(1). https:\/\/doi.org\/10.1186\/s13024-025-00890-5.","DOI":"10.1186\/s13024-025-00890-5"},{"key":"480_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04781-w","author":"R Raoufinia","year":"2025","unstructured":"Raoufinia R, Alyari G, Nia AT, Abbaszadegan MR, Mahmoudi A, Shafaeibajestan S, et al. Cutting-edge treatments in amyotrophic lateral sclerosis: the role of molecular pathogenesis in targeted therapies. Stem Cell Res Ther. 2025. https:\/\/doi.org\/10.1186\/s13287-025-04781-w.","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"480_CR61","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1093\/hmg\/ddt319","volume":"22","author":"W Wang","year":"2013","unstructured":"Wang W, Li L, Lin W-L, Dickson DW, Petrucelli L, Zhang T, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22(23):4706\u201319. https:\/\/doi.org\/10.1093\/hmg\/ddt319.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"480_CR62","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41593-019-0397-0","volume":"22","author":"SY Choi","year":"2019","unstructured":"Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, et al. C9ORF72-ALS\/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22(6):851\u201362. https:\/\/doi.org\/10.1038\/s41593-019-0397-0.","journal-title":"Nat Neurosci"},{"issue":"5","key":"480_CR63","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1471-4159.2006.03619.x","volume":"96","author":"M Damiano","year":"2006","unstructured":"Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu\/Zn\u2010superoxide dismutase mutant mice. J Neurochem. 2006;96(5):1349\u201361. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03619.x.","journal-title":"J Neurochem"},{"key":"480_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.phrs.2018.09.008","volume":"138","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Karam C, Yi J, Zhang L, Li X, Yoon D, et al. ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol Res. 2018;138:25\u201336. https:\/\/doi.org\/10.1016\/j.phrs.2018.09.008.","journal-title":"Pharmacol Res"},{"key":"480_CR65","doi-asserted-by":"publisher","unstructured":"Magr\u00ec A, Lipari CLR, Caccamo A, Battiato G, Conti Nibali S, De Pinto V, et al. AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS. Cell Death Discov. 2024;10(1). https:\/\/doi.org\/10.1038\/s41420-024-01949-w.","DOI":"10.1038\/s41420-024-01949-w"},{"issue":"1","key":"480_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","volume":"43","author":"P Pasinelli","year":"2004","unstructured":"Pasinelli P, Belford ME, Lennon N, Bacskai BJ, Hyman BT, Trotti D, et al. Amyotrophic Lateral Sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43(1):19\u201330. https:\/\/doi.org\/10.1016\/j.neuron.2004.06.021.","journal-title":"Neuron"},{"issue":"51","key":"480_CR67","doi-asserted-by":"publisher","first-page":"25991","DOI":"10.1073\/pnas.1902483116","volume":"116","author":"AdA Brasil","year":"2019","unstructured":"Brasil AdA, de Carvalho MDC, Gerhardt E, Queiroz DD, Pereira MD, Outeiro TF, et al. Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proc Natl Acad Sci U S A. 2019;116(51):25991\u20136000. https:\/\/doi.org\/10.1073\/pnas.1902483116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"480_CR68","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1038\/s44321-025-00323-2","volume":"17","author":"A Li","year":"2025","unstructured":"Li A, Huang S, Cao S-q, Lin J, Zhao L, Yu F, et al. Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy. EMBO Mol Med. 2025;17(11):3139\u201373. https:\/\/doi.org\/10.1038\/s44321-025-00323-2.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"480_CR69","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","volume":"92","author":"R Lopez-Gonzalez","year":"2016","unstructured":"Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, et al. Poly(GR) in C9ORF72 -related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92(2):383\u201391. https:\/\/doi.org\/10.1016\/j.neuron.2016.09.015.","journal-title":"Neuron"},{"key":"480_CR70","doi-asserted-by":"publisher","unstructured":"Schweingruber C, Nijssen J, Mechtersheimer J, Reber S, Leb\u0153uf M, O'Brien NL, et al. Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS. Nat Commun. 2025;16(1). https:\/\/doi.org\/10.1038\/s41467-025-59679-1.","DOI":"10.1038\/s41467-025-59679-1"},{"key":"480_CR71","doi-asserted-by":"publisher","unstructured":"Obrador E, Salvador R, L\u00f3pez-Blanch R, Jihad-Jebbar A, Vall\u00e9s SL, Estrela JM. Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis. Antioxidants. 2020;9(9). https:\/\/doi.org\/10.3390\/antiox9090901.","DOI":"10.3390\/antiox9090901"},{"key":"480_CR72","doi-asserted-by":"publisher","unstructured":"Li X, Jin S, Wang D, Wu Y, Tang X, Liu Y, et al. Accumulation of Damaging Lipids in the Arf1\u2010Ablated Neurons Promotes Neurodegeneration through Releasing mtDNA and Activating Inflammatory Pathways in Microglia. Adv Sci. 2025;12(16). https:\/\/doi.org\/10.1002\/advs.202414260.","DOI":"10.1002\/advs.202414260"},{"issue":"9","key":"480_CR73","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.biopsych.2017.12.014","volume":"83","author":"AA Nierenberg","year":"2018","unstructured":"Nierenberg AA, Ghaznavi SA, Sande MI, Ellard KK, Janos JA, Sylvia LG. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a novel target for bipolar disorder and other neuropsychiatric disorders. Biol Psychiatry. 2018;83(9):761\u20139. https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.014.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"480_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15698\/cst2018.01.120","volume":"2","author":"W Guo","year":"2018","unstructured":"Guo W, Van Den Bosch L. Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis. Cell Stress. 2018;2(1):14\u20136. https:\/\/doi.org\/10.15698\/cst2018.01.120.","journal-title":"Cell Stress"},{"key":"480_CR75","doi-asserted-by":"publisher","unstructured":"Tzeplaeff L, Wilfling S, Requardt MV, Herdick M. Current State and Future Directions in the Therapy of ALS. Cells. 2023;12(11). https:\/\/doi.org\/10.3390\/cells12111523.","DOI":"10.3390\/cells12111523"},{"issue":"12","key":"480_CR76","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","volume":"387","author":"TM Miller","year":"2022","unstructured":"Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, et al. Trial of antisense oligonucleotide Tofersen for SOD1 ALS. N Engl J Med. 2022;387(12):1099\u2013110. https:\/\/doi.org\/10.1056\/NEJMoa2204705.","journal-title":"N Engl J Med"},{"key":"480_CR77","doi-asserted-by":"publisher","unstructured":"Ludolph A, Wiesenfarth M. Tofersen and other antisense oligonucleotides in ALS. Ther Adv Neurol Disord. 2025;18. https:\/\/doi.org\/10.1177\/17562864251313915.","DOI":"10.1177\/17562864251313915"},{"key":"480_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202515849","author":"P Fu","year":"2026","unstructured":"Fu P, Zhang X, Zhou Y, Zheng J, Sun A, Zhuang K, et al. Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila. Adv Sci. 2026. https:\/\/doi.org\/10.1002\/advs.202515849.","journal-title":"Adv Sci"},{"issue":"10","key":"480_CR79","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1007\/s00415-023-11838-4","volume":"270","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Xu D, Huang H, Li D, Yang D, Zhou J, et al. The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2023;270(10):4729\u201343. https:\/\/doi.org\/10.1007\/s00415-023-11838-4.","journal-title":"J Neurol"},{"issue":"5","key":"480_CR80","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1586\/14737175.2015.1038244","volume":"15","author":"AQ Rana","year":"2015","unstructured":"Rana AQ, Ahmed US, Chaudry ZM, Vasan S. Parkinson\u2019s disease: a review of non-motor symptoms. Expert Rev Neurother. 2015;15(5):549\u201362. https:\/\/doi.org\/10.1586\/14737175.2015.1038244.","journal-title":"Expert Rev Neurother"},{"key":"480_CR81","doi-asserted-by":"publisher","unstructured":"Chhetri JK, Mei S, Wang C, Chan P. New horizons in Parkinson's disease in older populations. Age Ageing. 2023;52(10). https:\/\/doi.org\/10.1093\/ageing\/afad186.","DOI":"10.1093\/ageing\/afad186"},{"issue":"2","key":"480_CR82","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, et al. Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell. 2016;166(2):314\u201327. https:\/\/doi.org\/10.1016\/j.cell.2016.05.039.","journal-title":"Cell"},{"issue":"10","key":"480_CR83","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molmed.2024.07.003","volume":"30","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Yu J. LRRK2 in Parkinson\u2019s disease: upstream regulation and therapeutic targeting. Trends Mol Med. 2024;30(10):982\u201396. https:\/\/doi.org\/10.1016\/j.molmed.2024.07.003.","journal-title":"Trends Mol Med"},{"key":"480_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-70752-1","author":"Z-H Lin","year":"2026","unstructured":"Lin Z-H, Xue N-J, Liu Y, Zhang F, Si X-L, Zheng R, et al. Parkinson\u2019s disease-associated PLA2G6 protects IP3R1 protein to control ER-mitochondria tethering and Ca2+ transfer. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-70752-1.","journal-title":"Nat Commun"},{"key":"480_CR85","doi-asserted-by":"crossref","unstructured":"Das B, Dash SP, Mohanty S, Patel P. Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature. Reviews on New Drug Targets in Age-Related Disorders. Adv Exp Med Biol. 2021:65\u201376.","DOI":"10.1007\/978-3-030-55035-6_4"},{"issue":"3","key":"480_CR86","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s12035-024-04419-7","volume":"62","author":"S Le Bars","year":"2024","unstructured":"Le Bars S, Glaab E. Single-cell cortical transcriptomics reveals common and distinct changes in cell-cell communication in Alzheimer\u2019s and Parkinson\u2019s disease. Mol Neurobiol. 2024;62(3):2655\u201373. https:\/\/doi.org\/10.1007\/s12035-024-04419-7.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"480_CR87","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/revneuro-2022-0056","volume":"34","author":"W Shi","year":"2023","unstructured":"Shi W, Tan C, Liu C, Chen D. Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases. Rev Neurosci. 2023;34(3):275\u201394. https:\/\/doi.org\/10.1515\/revneuro-2022-0056.","journal-title":"Rev Neurosci"},{"key":"480_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/jci197183","author":"S Liu","year":"2026","unstructured":"Liu S, Ren Q, Mo G, Li Z, Huang H, Zhou Y, et al. m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria. J Clin Invest. 2026. https:\/\/doi.org\/10.1172\/jci197183.","journal-title":"J Clin Invest"},{"issue":"3","key":"480_CR89","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smaji\u0107","year":"2022","unstructured":"Smaji\u0107 S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145(3):964\u201378. https:\/\/doi.org\/10.1093\/brain\/awab446.","journal-title":"Brain"},{"issue":"11","key":"480_CR90","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Wei X, Yan H, Qin Y, Yan S, Liu J, et al. TREM2 deficiency aggravates \u03b1\u2010synuclein\u2013induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models. FASEB J. 2019;33(11):12164\u201374. https:\/\/doi.org\/10.1096\/fj.201900992R.","journal-title":"FASEB J"},{"key":"480_CR91","doi-asserted-by":"publisher","unstructured":"Wang X, Zhang T, Zhou X, Gong X, Fu X, Du T, et al. Disease Progression-Dependent Expression of CD200R1 and CX3CR1 in Mouse Models of Parkinson's Disease. Aging Dis. 2020;11(2). https:\/\/doi.org\/10.14336\/ad.2019.0615.","DOI":"10.14336\/ad.2019.0615"},{"issue":"10","key":"480_CR92","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","volume":"30","author":"S-Y Jiang","year":"2023","unstructured":"Jiang S-Y, Tian T, Yao H, Xia X-M, Wang C, Cao L, et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson\u2019s disease via LCN2-dependent astrocyte senescence. Cell Death Differ. 2023;30(10):2280\u201392. https:\/\/doi.org\/10.1038\/s41418-023-01216-y.","journal-title":"Cell Death Differ"},{"key":"480_CR93","doi-asserted-by":"publisher","unstructured":"Bantle CM, Hirst WD, Weihofen A, Shlevkov E. Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson's Disease? Front Cell Dev Biol. 2021;8. https:\/\/doi.org\/10.3389\/fcell.2020.608026.","DOI":"10.3389\/fcell.2020.608026"},{"key":"480_CR94","doi-asserted-by":"publisher","unstructured":"Ramazi S, Dadzadi M, Darvazi M, Seddigh N, Allahverdi A. Protein modification in neurodegenerative diseases. MedComm. 2024;5(8). https:\/\/doi.org\/10.1002\/mco2.674.","DOI":"10.1002\/mco2.674"},{"key":"480_CR95","doi-asserted-by":"publisher","unstructured":"Li H, Sun B, Huang Y, Zhang J, Xu X, Shen Y, et al. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo. Mol Med. 2022;28(1). https:\/\/doi.org\/10.1186\/s10020-022-00456-x.","DOI":"10.1186\/s10020-022-00456-x"},{"issue":"7","key":"480_CR96","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri F, Snaidero N, Kleinberger G, Madore C, Daria A, Werner G, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18(7):1186\u201398. https:\/\/doi.org\/10.15252\/embr.201743922.","journal-title":"EMBO Rep"},{"key":"480_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.02.023","author":"S Du","year":"2026","unstructured":"Du S, Long Q, Zhou Y, Fu J, Wu H, Yang L, et al. Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson\u2019s disease models. Cell. 2026. https:\/\/doi.org\/10.1016\/j.cell.2026.02.023.","journal-title":"Cell"},{"issue":"9557","key":"480_CR98","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/s0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369(9557):218\u201328. https:\/\/doi.org\/10.1016\/s0140-6736(07)60111-1.","journal-title":"Lancet"},{"key":"480_CR99","doi-asserted-by":"publisher","unstructured":"D\u2019Egidio F, Qosja E, Ammannito F, Topi S, d'Angelo M, Cimini A, et al. Antioxidant and Anti-Inflammatory Defenses in Huntington's Disease: Roles of NRF2 and PGC-1\u03b1, and Therapeutic Strategies. Life. 2025;15(4). https:\/\/doi.org\/10.3390\/life15040577.","DOI":"10.3390\/life15040577"},{"issue":"1","key":"480_CR100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1\u03b1 by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127(1):59\u201369. https:\/\/doi.org\/10.1016\/j.cell.2006.09.015.","journal-title":"Cell"},{"key":"480_CR101","doi-asserted-by":"publisher","unstructured":"Cal\u00ec C, Cantando I, Veloz Castillo MF, Gonzalez L, Bezzi P. Metabolic Reprogramming of Astrocytes in Pathological Conditions: Implications for Neurodegenerative Diseases. Int J Mol Sci. 2024;25(16). https:\/\/doi.org\/10.3390\/ijms25168922.","DOI":"10.3390\/ijms25168922"},{"key":"480_CR102","doi-asserted-by":"publisher","DOI":"10.1172\/jci196094","author":"M Lu","year":"2026","unstructured":"Lu M, Li K, Wu S, Zheng Z, Li X, Wang S, et al. SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington\u2019s disease models. J Clin Invest. 2026. https:\/\/doi.org\/10.1172\/jci196094.","journal-title":"J Clin Invest"},{"key":"480_CR103","doi-asserted-by":"publisher","unstructured":"Schrank S, Barrington N, Stutzmann GE. Calcium-Handling Defects and Neurodegenerative Disease. Cold Spring Harb Perspect Biol. 2020;12(7). https:\/\/doi.org\/10.1101\/cshperspect.a035212.","DOI":"10.1101\/cshperspect.a035212"},{"issue":"5","key":"480_CR104","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.neuron.2010.11.010","volume":"68","author":"T Higo","year":"2010","unstructured":"Higo T, Hamada K, Hisatsune C, Nukina N, Hashikawa T, Hattori M, et al. Mechanism of ER stress-induced brain damage by IP3 receptor. Neuron. 2010;68(5):865\u201378. https:\/\/doi.org\/10.1016\/j.neuron.2010.11.010.","journal-title":"Neuron"},{"issue":"1","key":"480_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2004.11.001","volume":"26","author":"X-J Li","year":"2005","unstructured":"Li X-J, Li S-H. HAP1 and intracellular trafficking. Trends Pharmacol Sci. 2005;26(1):1\u20133. https:\/\/doi.org\/10.1016\/j.tips.2004.11.001.","journal-title":"Trends Pharmacol Sci"},{"key":"480_CR106","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Flint Beal M. PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med. 2013;62:37\u201346. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.04.016.","journal-title":"Free Radic Biol Med"},{"key":"480_CR107","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awag028","author":"H Ishtayeh","year":"2026","unstructured":"Ishtayeh H, Battistoni E, Pochtar S, McHugh TLM, Tshilenge K-T, Rossmiller B, et al. Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington\u2019s disease. Brain. 2026. https:\/\/doi.org\/10.1093\/brain\/awag028.","journal-title":"Brain"},{"issue":"4","key":"480_CR108","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s43440-024-00619-z","volume":"76","author":"S Upadhayay","year":"2024","unstructured":"Upadhayay S, Kumar P. Mitochondrial targeted antioxidants as potential therapy for Huntington\u2019s disease. Pharmacol Rep. 2024;76(4):693\u2013713. https:\/\/doi.org\/10.1007\/s43440-024-00619-z.","journal-title":"Pharmacol Rep"},{"issue":"6","key":"480_CR109","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/mds.27010","volume":"32","author":"C Verny","year":"2017","unstructured":"Verny C, Bachoud\u2010L\u00e9vi AC, Durr A, Goizet C, Azulay JP, Simonin C, et al. A randomized, double\u2010blind, placebo\u2010controlled trial evaluating cysteamine in Huntington\u2019s disease. Mov Disord. 2017;32(6):932\u20136. https:\/\/doi.org\/10.1002\/mds.27010.","journal-title":"Mov Disord"},{"key":"480_CR110","doi-asserted-by":"publisher","unstructured":"Mochel F, M\u00e9neret A, Adanyeguh IM, Giron C, Hainque E, Luton M-P, et al. Effect of Triheptanoin on Caudate Atrophy and Motor Scores in Patients With Early-Stage Huntington Disease. Neurology. 2025;104(2). https:\/\/doi.org\/10.1212\/wnl.0000000000210194.","DOI":"10.1212\/wnl.0000000000210194"},{"key":"480_CR111","doi-asserted-by":"publisher","unstructured":"Bunting EL, Donaldson J, Cumming SA, Olive J, Broom E, Micl\u0103u\u0219 M, et al. Antisense oligonucleotide\u2013mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington's disease iPSC\u2013derived striatal neurons. Sci Transl Med. 2025;17(785). https:\/\/doi.org\/10.1126\/scitranslmed.adn4600.","DOI":"10.1126\/scitranslmed.adn4600"},{"issue":"6","key":"480_CR112","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2990.2008.00987.x","volume":"34","author":"D Mahad","year":"2008","unstructured":"Mahad D, Lassmann H, Turnbull D. Review: mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol. 2008;34(6):577\u201389. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.00987.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8006","key":"480_CR113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB, et al. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature. 2024;628(8006):195\u2013203. https:\/\/doi.org\/10.1038\/s41586-024-07167-9.","journal-title":"Nature"},{"key":"480_CR114","doi-asserted-by":"publisher","unstructured":"Clarkson BDS, Grund EM, Standiford MM, Mirchia K, Westphal MS, Muschler LS, et al. CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis. J Clin Invest. 2023;133(21). https:\/\/doi.org\/10.1172\/jci162788.","DOI":"10.1172\/jci162788"},{"key":"480_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612912","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza E, Matute C. Alterations of oligodendrocyte and myelin energy metabolism in Multiple Sclerosis. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241612912.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"480_CR116","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/s1474-4422(09)70043-2","volume":"8","author":"BD Trapp","year":"2009","unstructured":"Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009;8(3):280\u201391. https:\/\/doi.org\/10.1016\/s1474-4422(09)70043-2.","journal-title":"Lancet Neurol"},{"issue":"3","key":"480_CR117","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2010","unstructured":"Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol. 2010;69(3):481\u201392. https:\/\/doi.org\/10.1002\/ana.22109.","journal-title":"Ann Neurol"},{"issue":"3","key":"480_CR118","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/wco.0000000000001363","volume":"38","author":"B Cree","year":"2025","unstructured":"Cree B, Hartung H-P. Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success. Curr Opin Neurol. 2025;38(3):226\u201335. https:\/\/doi.org\/10.1097\/wco.0000000000001363.","journal-title":"Curr Opin Neurol"},{"key":"480_CR119","doi-asserted-by":"publisher","unstructured":"Carlstr\u00f6m KE, Zhu K, Ewing E, Krabbendam IE, Harris RA, Falc\u00e3o AM, et al. Gsta4 controls apoptosis of differentiating adult oligodendrocytes during homeostasis and remyelination via the mitochondria-associated Fas-Casp8-Bid-axis. Nat Commun. 2020;11(1). https:\/\/doi.org\/10.1038\/s41467-020-17871-5.","DOI":"10.1038\/s41467-020-17871-5"},{"issue":"7","key":"480_CR120","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10571-020-00910-6","volume":"41","author":"E Shiri","year":"2020","unstructured":"Shiri E, Pasbakhsh P, Borhani\u2011Haghighi M, Alizadeh Z, Nekoonam S, Mojaverrostami S, et al. Mesenchymal stem cells ameliorate Cuprizone-induced demyelination by targeting oxidative stress and mitochondrial dysfunction. Cell Mol Neurobiol. 2020;41(7):1467\u201381. https:\/\/doi.org\/10.1007\/s10571-020-00910-6.","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"480_CR121","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s1474-4422(25)00175-9","volume":"24","author":"K Reetz","year":"2025","unstructured":"Reetz K, Lischewski SA, Dogan I, Didszun C, Pishnamaz M, Konrad K, et al. Friedreich\u2019s Ataxia\u2014a rare multisystem disease. Lancet Neurol. 2025;24(7):614\u201324. https:\/\/doi.org\/10.1016\/s1474-4422(25)00175-9.","journal-title":"Lancet Neurol"},{"issue":"5254","key":"480_CR122","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 MD, Pianese L, Coss\u00e9e M, Cavalcanti F, et al. Friedreich\u2019s Ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271(5254):1423\u20137. https:\/\/doi.org\/10.1126\/science.271.5254.1423.","journal-title":"Science"},{"issue":"8097","key":"480_CR123","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-025-09822-1","volume":"649","author":"K Want","year":"2025","unstructured":"Want K, Gorny H, Turki E, Noiray M, Monfort B, Mor-Gautier R, et al. Cross-regulation of [2Fe\u20132S] cluster synthesis by ferredoxin-2 and frataxin. Nature. 2025;649(8097):721\u20138. https:\/\/doi.org\/10.1038\/s41586-025-09822-1.","journal-title":"Nature"},{"issue":"8097","key":"480_CR124","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41586-025-09821-2","volume":"649","author":"JD Meisel","year":"2025","unstructured":"Meisel JD, Joshi PR, Spelbring AN, Wang H, Wellner SM, Wiesenthal PP, et al. Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency. Nature. 2025;649(8097):713\u201320. https:\/\/doi.org\/10.1038\/s41586-025-09821-2.","journal-title":"Nature"},{"key":"480_CR125","doi-asserted-by":"publisher","unstructured":"Portillo-Carrasquer M, Sanz-Alc\u00e1zar A, S\u00e1nchez-L\u00f3pez B, Delaspre F, Pazos-Gil M, Oliveira-Jorge L, et al. Targeting frataxin deficiency in DRG neurons and fibroblasts: omaveloxolone restores metabolic and iron balance to reduce ferroptosis. Biomed Pharmacother. 2026;195. https:\/\/doi.org\/10.1016\/j.biopha.2026.119031.","DOI":"10.1016\/j.biopha.2026.119031"},{"key":"480_CR126","doi-asserted-by":"publisher","unstructured":"Campbell T, Slone J, Vu J, Liu W, Yang L, Dourson A, et al. Ferroptosis is a novel pathogenic mechanism of FDXR-related disease via disruption of the NRF2 pathway. Cell Death Discov. 2025;11(1). https:\/\/doi.org\/10.1038\/s41420-025-02840-y.","DOI":"10.1038\/s41420-025-02840-y"},{"issue":"8","key":"480_CR127","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","volume":"83","author":"A Lee","year":"2023","unstructured":"Lee A. Omaveloxolone: first approval. Drugs. 2023;83(8):725\u20139. https:\/\/doi.org\/10.1007\/s40265-023-01874-9.","journal-title":"Drugs"},{"key":"480_CR128","doi-asserted-by":"publisher","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther. 2023;244. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373.","DOI":"10.1016\/j.pharmthera.2023.108373"},{"issue":"2","key":"480_CR129","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ymthe.2025.10.048","volume":"34","author":"H Tang","year":"2026","unstructured":"Tang H, Gupte S, Xu E, Calabro KR, Friend H, Crosson SM, et al. Development of an AAV-based gene therapy for the ocular phenotype of Friedreich\u2019s ataxia. Mol Ther. 2026;34(2):771\u201388. https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.048.","journal-title":"Mol Ther"},{"issue":"4","key":"480_CR130","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tips.2016.12.006","volume":"38","author":"CJ Millard","year":"2017","unstructured":"Millard CJ, Watson PJ, Fairall L, Schwabe JWR. Targeting Class I histone deacetylases in a \u201ccomplex\u201d environment. Trends Pharmacol Sci. 2017;38(4):363\u201377. https:\/\/doi.org\/10.1016\/j.tips.2016.12.006.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"480_CR131","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mds.27604","volume":"34","author":"G Alfedi","year":"2019","unstructured":"Alfedi G, Luffarelli R, Cond\u00f2 I, Pedini G, Mannucci L, Massaro DS, et al. Drug repositioning screening identifies etravirine as a potential therapeutic for Friedreich\u2019s ataxia. Mov Disord. 2019;34(3):323\u201334. https:\/\/doi.org\/10.1002\/mds.27604.","journal-title":"Mov Disord"},{"issue":"1","key":"480_CR132","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53\u201389. https:\/\/doi.org\/10.1016\/j.preteyeres.2003.10.003.","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"480_CR133","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene\u2013environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132(9):2317\u201326. https:\/\/doi.org\/10.1093\/brain\/awp158.","journal-title":"Brain"},{"issue":"9","key":"480_CR134","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41433-019-0695-5","volume":"34","author":"F Darvizeh","year":"2019","unstructured":"Darvizeh F, Asanad S, Falavarjani KG, Wu J, Tian JJ, Bandello F, et al. Choroidal thickness and the retinal ganglion cell complex in chronic Leber\u02bcs hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography. Eye. 2019;34(9):1624\u201330. https:\/\/doi.org\/10.1038\/s41433-019-0695-5.","journal-title":"Eye"},{"key":"480_CR135","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mito.2017.01.004","volume":"36","author":"P Yu-Wai-Man","year":"2017","unstructured":"Yu-Wai-Man P, Soiferman D, Moore DG, Burt\u00e9 F, Saada A. Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy. Mitochondrion. 2017;36:36\u201342. https:\/\/doi.org\/10.1016\/j.mito.2017.01.004.","journal-title":"Mitochondrion"},{"issue":"9","key":"480_CR136","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(9):2677\u201386. https:\/\/doi.org\/10.1093\/brain\/awr170.","journal-title":"Brain"},{"issue":"9","key":"480_CR137","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1093\/brain\/awr180","volume":"134","author":"V Carelli","year":"2011","unstructured":"Carelli V, La Morgia C, Valentino ML, Rizzo G, Carbonelli M, De Negri AM, et al. Idebenone treatment in Leber\u2019s Hereditary Optic Neuropathy. Brain. 2011;134(9):e188-e. https:\/\/doi.org\/10.1093\/brain\/awr180.","journal-title":"Brain"},{"issue":"4","key":"480_CR138","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/wno.0000000000000570","volume":"37","author":"V Carelli","year":"2017","unstructured":"Carelli V, Carbonelli M, de Coo IF, Kawasaki A, Klopstock T, Lagr\u00e8ze WA, et al. International consensus statement on the clinical and therapeutic management of Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2017;37(4):371\u201381. https:\/\/doi.org\/10.1097\/wno.0000000000000570.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"480_CR139","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40265-020-01428-3","volume":"81","author":"G Amore","year":"2020","unstructured":"Amore G, Romagnoli M, Carbonelli M, Barboni P, Carelli V, La Morgia C. Therapeutic options in hereditary optic neuropathies. Drugs. 2020;81(1):57\u201386. https:\/\/doi.org\/10.1007\/s40265-020-01428-3.","journal-title":"Drugs"},{"key":"480_CR140","doi-asserted-by":"publisher","unstructured":"Leruez S, Verny C, Bonneau D, Procaccio V, Lenaers G, Amati-Bonneau P, et al. Cyclosporine A does not prevent second-eye involvement in Leber's hereditary optic neuropathy. Orphanet J Rare Dis. 2018;13(1). https:\/\/doi.org\/10.1186\/s13023-018-0773-y.","DOI":"10.1186\/s13023-018-0773-y"},{"key":"480_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/179412","volume":"2011","author":"RD Koilkonda","year":"2011","unstructured":"Koilkonda RD, Guy J. Leber\u2019s hereditary optic neuropathy-gene therapy: From benchtop to bedside. J Ophthalmol. 2011;2011:1\u201316. https:\/\/doi.org\/10.1155\/2011\/179412.","journal-title":"J Ophthalmol"},{"key":"480_CR142","doi-asserted-by":"publisher","unstructured":"Cwerman-Thibault H, Augustin S, Lechauve C, Ayache J, Ellouze S, Sahel J-A, et al. Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss. Mol Ther Methods Clin Dev. 2015;2. https:\/\/doi.org\/10.1038\/mtm.2015.3.","DOI":"10.1038\/mtm.2015.3"},{"issue":"3","key":"480_CR143","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","volume":"123","author":"WJ Feuer","year":"2016","unstructured":"Feuer WJ, Schiffman JC, Davis JL, Porciatti V, Gonzalez P, Koilkonda RD, et al. Gene therapy for Leber Hereditary Optic Neuropathy. Ophthalmology. 2016;123(3):558\u201370. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.025.","journal-title":"Ophthalmology"},{"issue":"6","key":"480_CR144","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ophtha.2017.12.036","volume":"125","author":"C Vignal","year":"2018","unstructured":"Vignal C, Uretsky S, Fitoussi S, Galy A, Blouin L, Girmens J-F, et al. Safety of rAAV2\/2-ND4 gene therapy for Leber Hereditary Optic Neuropathy. Ophthalmology. 2018;125(6):945\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.036.","journal-title":"Ophthalmology"},{"key":"480_CR145","doi-asserted-by":"publisher","unstructured":"Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Sadun AA, et al. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med. 2020;12(573). https:\/\/doi.org\/10.1126\/scitranslmed.aaz7423.","DOI":"10.1126\/scitranslmed.aaz7423"},{"issue":"5","key":"480_CR146","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","volume":"128","author":"NJ Newman","year":"2021","unstructured":"Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Biousse V, Vignal-Clermont C, et al. Efficacy and safety of intravitreal gene therapy for Leber Hereditary Optic Neuropathy treated within 6 months of disease onset. Ophthalmology. 2021;128(5):649\u201360. https:\/\/doi.org\/10.1016\/j.ophtha.2020.12.012.","journal-title":"Ophthalmology"},{"issue":"3","key":"480_CR147","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/wno.0000000000001367","volume":"41","author":"V Biousse","year":"2021","unstructured":"Biousse V, Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Vignal-Clermont C, et al. Long-term follow-up after unilateral intravitreal gene therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. J Neuroophthalmol. 2021;41(3):309\u201315. https:\/\/doi.org\/10.1097\/wno.0000000000001367.","journal-title":"J Neuroophthalmol"},{"key":"480_CR148","doi-asserted-by":"publisher","unstructured":"Peron C, Maresca A, Cavaliere A, Iannielli A, Broccoli V, Carelli V, et al. Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives. Front Neurol. 2021;12. https:\/\/doi.org\/10.3389\/fneur.2021.648916.","DOI":"10.3389\/fneur.2021.648916"},{"issue":"9","key":"480_CR149","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/hmg\/ddad001","volume":"32","author":"J-R Chen","year":"2023","unstructured":"Chen J-R, Chen C, Chen J, Ji Y, Lian Y, Zhang J, et al. Nuclear modifier YARS2 allele correction restored retinal ganglion cells-specific deficiencies in Leber\u2019s hereditary optic neuropathy. Hum Mol Genet. 2023;32(9):1539\u201351. https:\/\/doi.org\/10.1093\/hmg\/ddad001.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"480_CR150","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.cell.2020.08.013","volume":"182","author":"CS Cowan","year":"2020","unstructured":"Cowan CS, Renner M, De Gennaro M, Gross-Scherf B, Goldblum D, Hou Y, et al. Cell types of the human retina and its organoids at single-cell resolution. Cell. 2020;182(6):1623-40.e34. https:\/\/doi.org\/10.1016\/j.cell.2020.08.013.","journal-title":"Cell"},{"issue":"8","key":"480_CR151","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","volume":"120","author":"P Yu-Wai-Man","year":"2013","unstructured":"Yu-Wai-Man P, Chinnery PF. Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates. Ophthalmology. 2013;120(8):1712-.e1. https:\/\/doi.org\/10.1016\/j.ophtha.2013.04.022.","journal-title":"Ophthalmology"},{"issue":"10","key":"480_CR152","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1136\/bjo.2007.134726","volume":"92","author":"AC Cohn","year":"2008","unstructured":"Cohn AC, Toomes C, Hewitt AW, Kearns LS, Inglehearn CF, Craig JE, et al. The natural history of OPA1-related autosomal dominant optic atrophy. Br J Ophthalmol. 2008;92(10):1333\u20136. https:\/\/doi.org\/10.1136\/bjo.2007.134726.","journal-title":"Br J Ophthalmol"},{"key":"480_CR153","doi-asserted-by":"publisher","unstructured":"Lenaers G, Neutzner A, Le Dantec Y, J\u00fcschke C, Xiao T, Decembrini S, et al. Dominant optic atrophy: Culprit mitochondria in the optic nerve. Prog Retin Eye Res. 2021;83. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100935.","DOI":"10.1016\/j.preteyeres.2020.100935"},{"issue":"3","key":"480_CR154","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.survophthal.2019.11.001","volume":"65","author":"E Kisilevsky","year":"2020","unstructured":"Kisilevsky E, Freund P, Margolin E. Mitochondrial disorders and the eye. Surv Ophthalmol. 2020;65(3):294\u2013311. https:\/\/doi.org\/10.1016\/j.survophthal.2019.11.001.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"480_CR155","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2350-13-65","volume":"13","author":"GJ Almind","year":"2012","unstructured":"Almind GJ, Ek J, Rosenberg T, Eiberg H, Larsen M, LuCamp L, et al. Dominant optic atrophy in Denmark \u2013 report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%. BMC Med Genet. 2012;13(1):65. https:\/\/doi.org\/10.1186\/1471-2350-13-65.","journal-title":"BMC Med Genet"},{"issue":"6","key":"480_CR156","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","volume":"3","author":"H Eiberg","year":"1994","unstructured":"Eiberg H, Kjer B, Kjer P, Rosenberg T. Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. linkage analysis. Hum Mol Genet. 1994;3(6):977\u201380. https:\/\/doi.org\/10.1093\/hmg\/3.6.977.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"480_CR157","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ceca.2014.11.008","volume":"57","author":"L F\u00fcl\u00f6p","year":"2015","unstructured":"F\u00fcl\u00f6p L, Rajki A, Maka E, Moln\u00e1r MJ, Sp\u00e4t A. Mitochondrial Ca2+ uptake correlates with the severity of the symptoms in autosomal dominant optic atrophy. Cell Calcium. 2015;57(1):49\u201355. https:\/\/doi.org\/10.1016\/j.ceca.2014.11.008.","journal-title":"Cell Calcium"},{"issue":"1","key":"480_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1187-1","volume":"14","author":"B Le Roux","year":"2019","unstructured":"Le Roux B, Lenaers G, Zanlonghi X, Amati-Bonneau P, Chabrun F, Foulonneau T, et al. OPA1: 516 unique variants and 831 patients registered in an updated centralized variome database. Orphanet J Rare Dis. 2019;14(1):1. https:\/\/doi.org\/10.1186\/s13023-019-1187-1.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"480_CR159","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/brain\/awr330","volume":"135","author":"PA Williams","year":"2012","unstructured":"Williams PA, Piechota M, von Ruhland C, Taylor E, Morgan JE, Votruba M. Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity. Brain. 2012;135(2):493\u2013505. https:\/\/doi.org\/10.1093\/brain\/awr330.","journal-title":"Brain"},{"issue":"10","key":"480_CR160","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1093\/brain\/awq218","volume":"133","author":"PA Williams","year":"2010","unstructured":"Williams PA, Morgan JE, Votruba M. Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy. Brain. 2010;133(10):2942\u201351. https:\/\/doi.org\/10.1093\/brain\/awq218.","journal-title":"Brain"},{"issue":"8","key":"480_CR161","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/hmg\/ddaa047","volume":"29","author":"C Zanna","year":"2020","unstructured":"Zanna C, Reynier P, Lenaers G, Bonneau D, Procaccio V, Simard G, et al. Metabolomics hallmarks OPA1 variants correlating with their in vitro phenotype and predicting clinical severity. Hum Mol Genet. 2020;29(8):1319\u201329. https:\/\/doi.org\/10.1093\/hmg\/ddaa047.","journal-title":"Hum Mol Genet"},{"key":"480_CR162","doi-asserted-by":"publisher","unstructured":"Borrelli E, Bandello F, Boon CJF, Carelli V, Lenaers G, Reibaldi M, et al. Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management. Prog Retin Eye Res. 2024;101. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101264.","DOI":"10.1016\/j.preteyeres.2024.101264"},{"issue":"2","key":"480_CR163","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26(2):211\u20135. https:\/\/doi.org\/10.1038\/79944.","journal-title":"Nat Genet"},{"issue":"2","key":"480_CR164","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26(2):207\u201310. https:\/\/doi.org\/10.1038\/79936.","journal-title":"Nat Genet"},{"issue":"9","key":"480_CR165","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1136\/jmg.2003.016576","volume":"41","author":"P Reynier","year":"2004","unstructured":"Reynier P. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet. 2004;41(9):e110-e. https:\/\/doi.org\/10.1136\/jmg.2003.016576.","journal-title":"J Med Genet"},{"issue":"5","key":"480_CR166","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Z\u00fcchner","year":"2004","unstructured":"Z\u00fcchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet. 2004;36(5):449\u201351. https:\/\/doi.org\/10.1038\/ng1341.","journal-title":"Nat Genet"},{"issue":"2","key":"480_CR167","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.20797","volume":"59","author":"S Z\u00fcchner","year":"2006","unstructured":"Z\u00fcchner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol. 2006;59(2):276\u201381. https:\/\/doi.org\/10.1002\/ana.20797.","journal-title":"Ann Neurol"},{"key":"480_CR168","doi-asserted-by":"publisher","unstructured":"Charif M, Chevrollier A, Gueguen N, Bris C, Gouden\u00e8ge D, Desquiret-Dumas V, et al. Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy. Neurol Genet. 2020;6(3). https:\/\/doi.org\/10.1212\/nxg.0000000000000428.","DOI":"10.1212\/nxg.0000000000000428"},{"issue":"7","key":"480_CR169","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1007\/s12035-023-03768-z","volume":"61","author":"R Ghosh Dastidar","year":"2023","unstructured":"Ghosh Dastidar R, Banerjee S, Lal PB, Ghosh Dastidar S. Multifaceted roles of AFG3L2, a mitochondrial ATPase in relation to neurological disorders. Mol Neurobiol. 2023;61(7):3788\u2013808. https:\/\/doi.org\/10.1007\/s12035-023-03768-z.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"480_CR170","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/brain\/awx219","volume":"140","author":"S Gerber","year":"2017","unstructured":"Gerber S, Charif M, Chevrollier A, Chaumette T, Angebault C, Kane MS, et al. Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission. Brain. 2017;140(10):2586\u201396. https:\/\/doi.org\/10.1093\/brain\/awx219.","journal-title":"Brain"},{"issue":"5","key":"480_CR171","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1684\/epd.2022.1474","volume":"24","author":"AC De Souza Crippa","year":"2022","unstructured":"De Souza Crippa AC, Franklin GL, Takeshita BT, Ghizoni Teive HA. DNM1L mutation presenting as progressive myoclonic epilepsy associated with acute febrile infection\u2010related epilepsy syndrome. Epileptic Disord. 2022;24(5):976\u20138. https:\/\/doi.org\/10.1684\/epd.2022.1474.","journal-title":"Epileptic Disord"},{"issue":"1","key":"480_CR172","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1172\/jci128514","volume":"130","author":"V Del Dotto","year":"2019","unstructured":"Del Dotto V, Ullah F, Di Meo I, Magini P, Gusic M, Maresca A, et al. SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder. J Clin Invest. 2019;130(1):108\u201325. https:\/\/doi.org\/10.1172\/jci128514.","journal-title":"J Clin Invest"},{"issue":"4","key":"480_CR173","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.survophthal.2023.01.012","volume":"68","author":"C de Muijnck","year":"2023","unstructured":"de Muijnck C, Brink JBt, Bergen AA, Boon CJF, van Genderen MM. Delineating Wolfram-like syndrome: a systematic review and discussion of the WFS1-associated disease spectrum. Surv Ophthalmol. 2023;68(4):641\u201354. https:\/\/doi.org\/10.1016\/j.survophthal.2023.01.012.","journal-title":"Surv Ophthalmol"},{"key":"480_CR174","doi-asserted-by":"publisher","unstructured":"Bonzano S, Dallorto E, Molineris I, Michelon F, Crisci I, Gambarotta G, et al. NR2F1 shapes mitochondria in the mouse brain, providing new insights into Bosch-Boonstra-Schaaf optic atrophy syndrome. Dis Model Mech. 2023;16(6). https:\/\/doi.org\/10.1242\/dmm.049854.","DOI":"10.1242\/dmm.049854"},{"key":"480_CR175","doi-asserted-by":"publisher","unstructured":"Bonzano S, Dallorto E, Bovetti S, Studer M, De Marchis S. Mitochondrial regulation of adult hippocampal neurogenesis: Insights into neurological function and neurodevelopmental disorders. Neurobiol Dis. 2024;199. https:\/\/doi.org\/10.1016\/j.nbd.2024.106604.","DOI":"10.1016\/j.nbd.2024.106604"},{"issue":"2","key":"480_CR176","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cmet.2015.06.006","volume":"22","author":"PHGM Willems","year":"2015","unstructured":"Willems PHGM, Rossignol R, Dieteren CEJ, Murphy MP, Koopman WJH. Redox homeostasis and mitochondrial dynamics. Cell Metab. 2015;22(2):207\u201318. https:\/\/doi.org\/10.1016\/j.cmet.2015.06.006.","journal-title":"Cell Metab"},{"issue":"9","key":"480_CR177","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbabio.2018.04.006","volume":"1859","author":"V Giorgio","year":"2018","unstructured":"Giorgio V, Schiavone M, Galber C, Carini M, Da Ros T, Petronilli V, et al. The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects. Biochim Biophys Acta Bioenerg. 2018;1859(9):901\u20138. https:\/\/doi.org\/10.1016\/j.bbabio.2018.04.006.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"480_CR178","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.phrs.2018.02.018","volume":"131","author":"V Del Dotto","year":"2018","unstructured":"Del Dotto V, Fogazza M, Lenaers G, Rugolo M, Carelli V, Zanna C. OPA1: how much do we know to approach therapy? Pharmacol Res. 2018;131:199\u2013210. https:\/\/doi.org\/10.1016\/j.phrs.2018.02.018.","journal-title":"Pharmacol Res"},{"key":"480_CR179","doi-asserted-by":"publisher","unstructured":"Sladen PE, Perdig\u00e3o PRL, Salsbury G, Novoselova T, van der Spuy J, Chapple JP, et al. CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs. Mol Ther Nucleic Acids. 2021;26:432\u201343. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.015.","DOI":"10.1016\/j.omtn.2021.08.015"},{"issue":"12","key":"480_CR180","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/brain\/aws303","volume":"135","author":"E Sarzi","year":"2012","unstructured":"Sarzi E, Angebault C, Seveno M, Gueguen N, Chaix B, Bielicki G, et al. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse. Brain. 2012;135(12):3599\u2013613. https:\/\/doi.org\/10.1093\/brain\/aws303.","journal-title":"Brain"},{"issue":"1","key":"480_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17821-1","volume":"11","author":"M Zaninello","year":"2020","unstructured":"Zaninello M, Palikaras K, Naon D, Iwata K, Herkenne S, Quintana-Cabrera R, et al. Inhibition of autophagy curtails visual loss in a model of autosomal dominant optic atrophy. Nat Commun. 2020;11(1):1. https:\/\/doi.org\/10.1038\/s41467-020-17821-1.","journal-title":"Nat Commun"},{"issue":"5","key":"480_CR182","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00415-015-7710-y","volume":"262","author":"M Mancuso","year":"2015","unstructured":"Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, et al. Redefining phenotypes associated with mitochondrial DNA single deletion. J Neurol. 2015;262(5):1301\u20139. https:\/\/doi.org\/10.1007\/s00415-015-7710-y.","journal-title":"J Neurol"},{"key":"480_CR183","doi-asserted-by":"publisher","unstructured":"Kierdaszuk B, Kaliszewska M, Rusecka J, Kosi\u0144ska J, Bartnik E, To\u0144ska K, et al. Progressive External Ophthalmoplegia in Polish Patients\u2014From Clinical Evaluation to Genetic Confirmation. Genes. 2020;12(1). https:\/\/doi.org\/10.3390\/genes12010054.","DOI":"10.3390\/genes12010054"},{"issue":"6","key":"480_CR184","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/IOP.0b013e3181cb57a7","volume":"26","author":"FAA de Castro","year":"2010","unstructured":"de Castro FAA, Cruz AAV, Sobreira CFdR. Brow motility in mitochondrial myopathy. Ophthal Plast Reconstr Surg. 2010;26(6):416\u20139. https:\/\/doi.org\/10.1097\/IOP.0b013e3181cb57a7.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"480_CR185","doi-asserted-by":"publisher","unstructured":"A rare case of Kearns\u2013Sayre syndrome in a 17-year-old Venezuelan male with bilateral ptosis as the initial presentation. Oxf Med Case Reports. 2016. https:\/\/doi.org\/10.1093\/omcr\/omw007.","DOI":"10.1093\/omcr\/omw007"},{"key":"480_CR186","doi-asserted-by":"publisher","unstructured":"Grigalionien\u0117 K, Burnyt\u0117 B, Balkelien\u0117 D, Ambrozaityt\u0117 L, Utkus A. Kearns\u2010Sayre syndrome case. Novel 5,9 kb mtDNA deletion. Mol Genet Genomic Med. 2022;11(1). https:\/\/doi.org\/10.1002\/mgg3.2059.","DOI":"10.1002\/mgg3.2059"},{"key":"480_CR187","doi-asserted-by":"publisher","unstructured":"Jacoby E, Bar-Yosef O, Gruber N, Lahav E, Varda-Bloom N, Bolkier Y, et al. Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes. Sci Transl Med. 2022;14(676). https:\/\/doi.org\/10.1126\/scitranslmed.abo3724.","DOI":"10.1126\/scitranslmed.abo3724"},{"key":"480_CR188","doi-asserted-by":"publisher","unstructured":"Angebault C, Fauconnier J, Patergnani S, Rieusset J, Danese A, Affortit CA, et al. ER-mitochondria cross-talk is regulated by the Ca 2+ sensor NCS1 and is impaired in Wolfram syndrome. Sci Signal. 2018;11(553). https:\/\/doi.org\/10.1126\/scisignal.aaq1380.","DOI":"10.1126\/scisignal.aaq1380"},{"key":"480_CR189","doi-asserted-by":"publisher","unstructured":"Blackstone C, Cagalinec M, Liiv M, Hodurova Z, Hickey MA, Vaarmann A, et al. Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome. PLoS Biol. 2016;14(7). https:\/\/doi.org\/10.1371\/journal.pbio.1002511.","DOI":"10.1371\/journal.pbio.1002511"},{"issue":"1","key":"480_CR190","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00125-024-06307-0","volume":"68","author":"R Chimienti","year":"2024","unstructured":"Chimienti R, Torchio S, Siracusano G, Zamarian V, Monaco L, Lombardo MT, et al. A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome. Diabetologia. 2024;68(1):128\u201351. https:\/\/doi.org\/10.1007\/s00125-024-06307-0.","journal-title":"Diabetologia"},{"issue":"10","key":"480_CR191","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.tips.2019.07.011","volume":"40","author":"D Abreu","year":"2019","unstructured":"Abreu D, Urano F. Current Landscape of Treatments for Wolfram Syndrome. Trends Pharmacol Sci. 2019;40(10):711\u20134. https:\/\/doi.org\/10.1016\/j.tips.2019.07.011.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"480_CR192","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2337\/db13-0717","volume":"63","author":"L Shang","year":"2014","unstructured":"Shang L, Hua H, Foo K, Martinez H, Watanabe K, Zimmer M, et al. \u03b2-Cell Dysfunction Due to Increased ER Stress in a Stem Cell Model of Wolfram Syndrome. Diabetes. 2014;63(3):923\u201333. https:\/\/doi.org\/10.2337\/db13-0717.","journal-title":"Diabetes"},{"key":"480_CR193","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145188","author":"D Abreu","year":"2021","unstructured":"Abreu D, Stone SI, Pearson TS, Bucelli RC, Simpson AN, Hurst S, et al. A phase 1b\/2a clinical trial of dantrolene sodium in patients with Wolfram syndrome. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.145188.","journal-title":"JCI Insight"},{"key":"480_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9412676","volume":"2018","author":"NB Toppings","year":"2018","unstructured":"Toppings NB, McMillan JM, Au PYB, Suchowersky O, Donovan LE. Wolfram Syndrome: A Case Report and Review of Clinical Manifestations, Genetics Pathophysiology, and Potential Therapies. Case Rep Endocrinol. 2018;2018:1\u20138. https:\/\/doi.org\/10.1155\/2018\/9412676.","journal-title":"Case Rep Endocrinol"},{"issue":"2","key":"480_CR195","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jcjd.2018.06.007","volume":"43","author":"M Toots","year":"2019","unstructured":"Toots M, Reimets R, Plaas M, Vasar E. Muscarinic Agonist Ameliorates Insulin Secretion in Wfs1-Deficient Mice. Can J Diabetes. 2019;43(2):115\u201320. https:\/\/doi.org\/10.1016\/j.jcjd.2018.06.007.","journal-title":"Can J Diabetes"},{"issue":"3","key":"480_CR196","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/en.2013-1519","volume":"155","author":"T Hara","year":"2014","unstructured":"Hara T, Mahadevan J, Kanekura K, Hara M, Lu S, Urano F. Calcium Efflux From the Endoplasmic Reticulum Leads to \u03b2-Cell Death. Endocrinology. 2014;155(3):758\u201368. https:\/\/doi.org\/10.1210\/en.2013-1519.","journal-title":"Endocrinology"},{"issue":"4","key":"480_CR197","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00125-009-1270-6","volume":"52","author":"M Akiyama","year":"2009","unstructured":"Akiyama M, Hatanaka M, Ohta Y, Ueda K, Yanai A, Uehara Y, et al. Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia. 2009;52(4):653\u201363. https:\/\/doi.org\/10.1007\/s00125-009-1270-6.","journal-title":"Diabetologia"},{"key":"480_CR198","doi-asserted-by":"publisher","unstructured":"Sobhani M, Zieglari A, Moniri E, Ahmad Panahi H, Daghighi Asli M. Graft hyper-branched dendrimer onto WS2 nanosheets modified Poly (N-Vinylcaprolactam) as a thermosensitive nanocarrier for Pioglitazone delivery using near-infrared radiation. Int J Pharm. 2021;607. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120985.","DOI":"10.1016\/j.ijpharm.2021.120985"},{"issue":"9","key":"480_CR199","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s40618-020-01228-2","volume":"43","author":"K Batjargal","year":"2020","unstructured":"Batjargal K, Tajima T, Jimbo EF, Yamagata T. Effect of 4-phenylbutyrate and valproate on dominant mutations of WFS1 gene in Wolfram syndrome. J Endocrinol Invest. 2020;43(9):1317\u201325. https:\/\/doi.org\/10.1007\/s40618-020-01228-2.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"480_CR200","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2015.4580","volume":"13","author":"X-Y Sun","year":"2016","unstructured":"Sun X-Y, Qin H-J, Zhang ZE, Xu YE, Yang X-C, Zhao D-M, et al. Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress-induced apoptosis. Mol Med Rep. 2016;13(1):661\u20138. https:\/\/doi.org\/10.3892\/mmr.2015.4580.","journal-title":"Mol Med Rep"},{"issue":"7","key":"480_CR201","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJMoa1903822","volume":"381","author":"WV Tamborlane","year":"2019","unstructured":"Tamborlane WV, Barrientos-P\u00e9rez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, et al. Liraglutide in children and adolescents with Type 2 Diabetes. N Engl J Med. 2019;381(7):637\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1903822.","journal-title":"N Engl J Med"},{"key":"480_CR202","doi-asserted-by":"publisher","unstructured":"Jagom\u00e4e T, Seppa K, Reimets R, Pastak M, Plaas M, Hickey MA, et al. Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype. Cells. 2021;10(11). https:\/\/doi.org\/10.3390\/cells10113193.","DOI":"10.3390\/cells10113193"},{"key":"480_CR203","doi-asserted-by":"publisher","unstructured":"Frontino G, Raouf T, Canarutto D, Tirelli E, Di Tonno R, Rigamonti A, et al. Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients. Front Pediatr. 2021;9. https:\/\/doi.org\/10.3389\/fped.2021.755365.","DOI":"10.3389\/fped.2021.755365"},{"issue":"8","key":"480_CR204","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1515\/jpem-2020-0699","volume":"34","author":"G Tarcin","year":"2021","unstructured":"Tarcin G, Turan H, Dagdeviren Cakir A, Ozer Y, Aykut A, Alpman Durmaz A, et al. Different clinical entities of the same mutation: a case report of three sisters with Wolfram syndrome and efficacy of dipeptidyl peptidase-4 inhibitor therapy. J Pediatr Endocrinol Metab. 2021;34(8):1049\u201353. https:\/\/doi.org\/10.1515\/jpem-2020-0699.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"480_CR205","doi-asserted-by":"publisher","unstructured":"Ju W-K, Perkins GA, Kim K-Y, Bastola T, Choi W-Y, Choi S-H. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells. Prog Retin Eye Res. 2023;95. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101136.","DOI":"10.1016\/j.preteyeres.2022.101136"},{"key":"480_CR206","doi-asserted-by":"publisher","unstructured":"Vavvas D, Van Bergen NJ, Crowston JG, Craig JE, Burdon KP, Kearns LS, et al. Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic Neuropathy. PLoS One. 2015;10(10). https:\/\/doi.org\/10.1371\/journal.pone.0140919.","DOI":"10.1371\/journal.pone.0140919"},{"issue":"8","key":"480_CR207","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41591-024-03068-6","volume":"30","author":"B Petriti","year":"2024","unstructured":"Petriti B, Rabiolo A, Chau K-Y, Williams PA, Montesano G, Lascaratos G, et al. Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss. Nat Med. 2024;30(8):2362\u201370. https:\/\/doi.org\/10.1038\/s41591-024-03068-6.","journal-title":"Nat Med"},{"issue":"4","key":"480_CR208","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/gim.2014.121","volume":"17","author":"P Sundaresan","year":"2015","unstructured":"Sundaresan P, Simpson DA, Sambare C, Duffy S, Lechner J, Dastane A, et al. Whole-mitochondrial genome sequencing in primary open-angle glaucoma using massively parallel sequencing identifies novel and known pathogenic variants. Genet Med. 2015;17(4):279\u201384. https:\/\/doi.org\/10.1038\/gim.2014.121.","journal-title":"Genet Med"},{"key":"480_CR209","doi-asserted-by":"publisher","unstructured":"He Y, Leung KW, Zhang Y-H, Duan S, Zhong X-F, Jiang R-Z, et al. Mitochondrial Complex I Defect Induces ROS Release and Degeneration in Trabecular Meshwork Cells of POAG Patients: Protection by Antioxidants. Invest Ophthalmol Vis Sci. 2008;49(4). https:\/\/doi.org\/10.1167\/iovs.07-1361.","DOI":"10.1167\/iovs.07-1361"},{"issue":"6326","key":"480_CR210","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V, et al. Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science. 2017;355(6326):756\u201360. https:\/\/doi.org\/10.1126\/science.aal0092.","journal-title":"Science"},{"key":"480_CR211","doi-asserted-by":"publisher","unstructured":"Ju W-K, Liu Q, Kim K-Y, Crowston JG, Lindsey JD, Agarwal N, et al. Elevated Hydrostatic Pressure Triggers Mitochondrial Fission and Decreases Cellular ATP in Differentiated RGC-5 Cells. Invest Ophthalmol Vis Sci. 2007;48(5). https:\/\/doi.org\/10.1167\/iovs.06-0573.","DOI":"10.1167\/iovs.06-0573"},{"key":"480_CR212","doi-asserted-by":"publisher","unstructured":"Izzotti A. Mitochondrial Damage in the Trabecular Meshwork of Patients With Glaucoma. Arch Ophthalmol. 2010;128(6). https:\/\/doi.org\/10.1001\/archophthalmol.2010.87.","DOI":"10.1001\/archophthalmol.2010.87"},{"key":"480_CR213","doi-asserted-by":"publisher","unstructured":"Kouassi Nzoughet J, Chao de la Barca JM, Guehlouz K, Leruez S, Coulbault L, Allouche S, et al. Nicotinamide Deficiency in Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2019;60(7). https:\/\/doi.org\/10.1167\/iovs.19-27099.","DOI":"10.1167\/iovs.19-27099"},{"key":"480_CR214","doi-asserted-by":"publisher","unstructured":"Tribble JR, J\u00f6e M, Varricchio C, Otmani A, Canovai A, Habchi B, et al. NMNAT2 is a druggable target to drive neuronal NAD production. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-50354-5.","DOI":"10.1038\/s41467-024-50354-5"},{"key":"480_CR215","doi-asserted-by":"publisher","unstructured":"Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM. Nicotinamide treatment robustly protects from inherited mouse glaucoma. Commun Integr Biol. 2018;11(1). https:\/\/doi.org\/10.1080\/19420889.2017.1356956.","DOI":"10.1080\/19420889.2017.1356956"},{"key":"480_CR216","doi-asserted-by":"publisher","unstructured":"Tribble JR, Otmani A, Sun S, Ellis SA, Cimaglia G, Vohra R, et al. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol. 2021;43. https:\/\/doi.org\/10.1016\/j.redox.2021.101988.","DOI":"10.1016\/j.redox.2021.101988"},{"issue":"4","key":"480_CR217","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1016\/j.bbrc.2018.08.016","volume":"503","author":"W-K Ju","year":"2018","unstructured":"Ju W-K, Shim MS, Kim K-Y, Bu JH, Park TL, Ahn S, et al. Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration. Biochem Biophys Res Commun. 2018;503(4):2639\u201345. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.016.","journal-title":"Biochem Biophys Res Commun"},{"key":"480_CR218","doi-asserted-by":"crossref","unstructured":"Nucci C, Tartaglione R, Cerulli A, Mancino R, Span\u00f2 A, Cavaliere F, et al. Retinal Damage Caused by High Intraocular Pressure\u2013Induced Transient Ischemia is Prevented by Coenzyme Q10 in Rat. Neuroinflammation in Neuronal Death and Repair. Int Rev Neurobiol. 2007:397\u2013406.","DOI":"10.1016\/S0074-7742(07)82022-8"},{"key":"480_CR219","doi-asserted-by":"publisher","unstructured":"Lee D, Shim MS, Kim K-Y, Noh YH, Kim H, Kim SY, et al. Coenzyme Q10 Inhibits Glutamate Excitotoxicity and Oxidative Stress\u2013Mediated Mitochondrial Alteration in a Mouse Model of Glaucoma. Invest Ophthalmol Vis Sci. 2014;55(2). https:\/\/doi.org\/10.1167\/iovs.13-12564.","DOI":"10.1167\/iovs.13-12564"},{"issue":"2","key":"480_CR220","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13311-021-01033-6","volume":"18","author":"Y van der Merwe","year":"2021","unstructured":"van der Merwe Y, Murphy MC, Sims JR, Faiq MA, Yang X-L, Ho LC, et al. Citicoline modulates glaucomatous neurodegeneration through intraocular pressure-independent control. Neurotherapeutics. 2021;18(2):1339\u201359. https:\/\/doi.org\/10.1007\/s13311-021-01033-6.","journal-title":"Neurotherapeutics"},{"issue":"16","key":"480_CR221","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/00001756-200211150-00023","volume":"13","author":"T Oshitari","year":"2002","unstructured":"Oshitari T, Fujimoto N, Adachi-Usami E. Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina. NeuroReport. 2002;13(16):2109\u201311. https:\/\/doi.org\/10.1097\/00001756-200211150-00023.","journal-title":"NeuroReport"},{"issue":"1","key":"480_CR222","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","volume":"110","author":"V Parisi","year":"2005","unstructured":"Parisi V. Electrophysiological assessment of glaucomatous visual dysfunction during treatment with Cytidine-5\u2032-diphosphocholine (citicoline): a study of 8 years of follow-up. Doc Ophthalmol. 2005;110(1):91\u2013102. https:\/\/doi.org\/10.1007\/s10633-005-7348-7.","journal-title":"Doc Ophthalmol"},{"issue":"5903","key":"480_CR223","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1126\/science.1161566","volume":"322","author":"KK Park","year":"2008","unstructured":"Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN\/mTOR pathway. Science. 2008;322(5903):963\u20136. https:\/\/doi.org\/10.1126\/science.1161566.","journal-title":"Science"},{"key":"480_CR224","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.exer.2012.11.022","volume":"108","author":"AP Vin","year":"2013","unstructured":"Vin AP, Hu H, Zhai Y, Von Zee CL, Logeman A, Stubbs EB, et al. Neuroprotective effect of Resveratrol prophylaxis on experimental retinal ischemic injury. Exp Eye Res. 2013;108:72\u20135. https:\/\/doi.org\/10.1016\/j.exer.2012.11.022.","journal-title":"Exp Eye Res"},{"key":"480_CR225","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4711","author":"Y Pang","year":"2020","unstructured":"Pang Y, Qin M, Hu P, Ji K, Xiao R, Sun N, et al. Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression. Int J Mol Med. 2020. https:\/\/doi.org\/10.3892\/ijmm.2020.4711.","journal-title":"Int J Mol Med"},{"issue":"5","key":"480_CR226","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.neurobiolaging.2014.12.021","volume":"36","author":"JD Lindsey","year":"2015","unstructured":"Lindsey JD, Duong-Polk KX, Hammond D, Leung CK-s, Weinreb RN. Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol. Neurobiol Aging. 2015;36(5):1969\u201381. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.12.021.","journal-title":"Neurobiol Aging"},{"key":"480_CR227","doi-asserted-by":"publisher","unstructured":"Avotri S, Eatman D, Russell-Randall K. Effects of Resveratrol on Inflammatory Biomarkers in Glaucomatous Human Trabecular Meshwork Cells. Nutrients. 2019;11(5). https:\/\/doi.org\/10.3390\/nu11050984.","DOI":"10.3390\/nu11050984"},{"issue":"52","key":"480_CR228","doi-asserted-by":"publisher","first-page":"33619","DOI":"10.1073\/pnas.2014213117","volume":"117","author":"JM Harder","year":"2020","unstructured":"Harder JM, Guymer C, Wood JPM, Daskalaki E, Chidlow G, Zhang C, et al. Disturbed glucose and Pyruvate metabolism in glaucoma with neuroprotection by Pyruvate or Rapamycin. Proc Natl Acad Sci U S A. 2020;117(52):33619\u201327. https:\/\/doi.org\/10.1073\/pnas.2014213117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"480_CR229","doi-asserted-by":"publisher","unstructured":"Harun-Or-Rashid M, Pappenhagen N, Zubricky R, Coughlin L, Jassim AH, Inman DM. MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma. Neurobiol Dis. 2020;141. https:\/\/doi.org\/10.1016\/j.nbd.2020.104944.","DOI":"10.1016\/j.nbd.2020.104944"},{"issue":"22","key":"480_CR230","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1523\/jneurosci.3652-17.2018","volume":"38","author":"M Harun-Or-Rashid","year":"2018","unstructured":"Harun-Or-Rashid M, Pappenhagen N, Palmer PG, Smith MA, Gevorgyan V, Wilson GN, et al. Structural and functional rescue of chronic metabolically stressed optic nerves through respiration. J Neurosci. 2018;38(22):5122\u201339. https:\/\/doi.org\/10.1523\/jneurosci.3652-17.2018.","journal-title":"J Neurosci"},{"issue":"12","key":"480_CR231","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00417-010-1425-7","volume":"248","author":"S Thaler","year":"2010","unstructured":"Thaler S, Choragiewicz TJ, Rejdak R, Fiedorowicz M, Turski WA, Tulidowicz-Bielak M, et al. Neuroprotection by Acetoacetate and \u03b2-hydroxybutyrate against NMDA-induced RGC damage in rat\u2014possible involvement of Kynurenic acid. Graefes Arch Clin Exp Ophthalmol. 2010;248(12):1729\u201335. https:\/\/doi.org\/10.1007\/s00417-010-1425-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"480_CR232","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3 ) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol. 2020;48(7):903\u201314. https:\/\/doi.org\/10.1111\/ceo.13818.","journal-title":"Clin Exp Ophthalmol"},{"key":"480_CR233","doi-asserted-by":"publisher","unstructured":"Dai Y, Hu X, Sun X. Overexpression of parkin protects retinal ganglion cells in experimental glaucoma. Cell Death Dis. 2018;9(2). https:\/\/doi.org\/10.1038\/s41419-017-0146-9.","DOI":"10.1038\/s41419-017-0146-9"},{"key":"480_CR234","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Loygorri JI, Ben\u00edtez-Fern\u00e1ndez R, Viedma-Poyatos \u00c1, Zapata-Mu\u00f1oz J, Villarejo-Zori B, G\u00f3mez-Sintes R, et al. Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens. Prog Retin Eye Res. 2023;96. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101205.","DOI":"10.1016\/j.preteyeres.2023.101205"},{"key":"480_CR235","doi-asserted-by":"publisher","unstructured":"Sayyad Z, Vishwakarma S, Dave TV, Naik MN, Radha V, Kaur I, et al. Human primary retinal cells as an in-vitro model for investigating defective signalling caused by OPTN mutants associated with glaucoma. Neurochem Int. 2021;148. https:\/\/doi.org\/10.1016\/j.neuint.2021.105075.","DOI":"10.1016\/j.neuint.2021.105075"},{"issue":"3","key":"480_CR236","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ymthe.2025.01.028","volume":"33","author":"AJ Clare","year":"2025","unstructured":"Clare AJ, Langer PM, Ward A, Chan YK, Dick AD, Copland DA. Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age. Mol Ther. 2025;33(3):1246\u201363. https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.028.","journal-title":"Mol Ther"},{"key":"480_CR237","doi-asserted-by":"publisher","unstructured":"Radu M, Br\u0103ni\u0219teanu DC, Pirvulescu RA, Dumitrescu OM, Ionescu MA, Zemba M. Exploring Stem-Cell-Based Therapies for Retinal Regeneration. Life. 2024;14(6). https:\/\/doi.org\/10.3390\/life14060668.","DOI":"10.3390\/life14060668"},{"key":"480_CR238","doi-asserted-by":"publisher","unstructured":"Montenegro L, Turnaturi R, Parenti C, Pasquinucci L. Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy. Nanomaterials. 2018;8(2). https:\/\/doi.org\/10.3390\/nano8020087.","DOI":"10.3390\/nano8020087"},{"key":"480_CR239","doi-asserted-by":"publisher","unstructured":"Soundara Pandi SP, Winter H, Smith MR, Harkin K, Bojdo J. Preclinical Retinal Disease Models: Applications in Drug Development and Transl Res. Pharmaceuticals. 2025;18(3). https:\/\/doi.org\/10.3390\/ph18030293.","DOI":"10.3390\/ph18030293"},{"key":"480_CR240","doi-asserted-by":"publisher","unstructured":"Lu W, Hu H, S\u00e9vigny J, Gabelt BAT, Kaufman PL, Johnson EC, et al. Rat, Mouse, and Primate Models of Chronic Glaucoma Show Sustained Elevation of Extracellular ATP and Altered Purinergic Signaling in the Posterior Eye. Invest Ophthalmol Vis Sci. 2015;56(5). https:\/\/doi.org\/10.1167\/iovs.14-15891.","DOI":"10.1167\/iovs.14-15891"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00480-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:35:46Z","timestamp":1779935746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00480-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":240,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00480-x","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}